Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Inflammation is associated with the remodeling of calcific aortic valve disease.

Coté N, Mahmut A, Bosse Y, Couture C, Pagé S, Trahan S, Boulanger MC, Fournier D, Pibarot P, Mathieu P.

Inflammation. 2013 Jun;36(3):573-81. doi: 10.1007/s10753-012-9579-6.

PMID:
23225202
2.

The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops.

Li C, Xu S, Gotlieb AI.

Cardiovasc Pathol. 2013 Jan-Feb;22(1):1-8. doi: 10.1016/j.carpath.2012.06.005. Review.

PMID:
22795219
3.

Calcific aortic valve stenosis: Immunohistochemical analysis of inflammatory infiltrate.

Steiner I, Krbal L, Rozkoš T, Harrer J, Laco J.

Pathol Res Pract. 2012 Apr 15;208(4):231-4. doi: 10.1016/j.prp.2012.02.009.

PMID:
22436689
4.

Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis.

Moreno PR, Astudillo L, Elmariah S, Purushothaman KR, Purushothaman M, Lento PA, Sharma SK, Fuster V, Adams DH.

J Thorac Cardiovasc Surg. 2011 Oct;142(4):895-901. doi: 10.1016/j.jtcvs.2011.03.002.

5.

Amyloid substance within stenotic aortic valves promotes mineralization.

Audet A, Côté N, Couture C, Bossé Y, Després JP, Pibarot P, Mathieu P.

Histopathology. 2012 Oct;61(4):610-9. doi: 10.1111/j.1365-2559.2012.04265.x.

PMID:
22642224
6.

Osseous and chondromatous metaplasia in calcific aortic valve stenosis.

Torre M, Hwang DH, Padera RF, Mitchell RN, VanderLaan PA.

Cardiovasc Pathol. 2016 Jan-Feb;25(1):18-24. doi: 10.1016/j.carpath.2015.08.008.

7.

P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease.

El Husseini D, Boulanger MC, Mahmut A, Bouchareb R, Laflamme MH, Fournier D, Pibarot P, Bossé Y, Mathieu P.

J Mol Cell Cardiol. 2014 Jul;72:146-56. doi: 10.1016/j.yjmcc.2014.02.014.

PMID:
24631773
8.

Innate and Adaptive Immunity in Calcific Aortic Valve Disease.

Mathieu P, Bouchareb R, Boulanger MC.

J Immunol Res. 2015;2015:851945. doi: 10.1155/2015/851945. Review.

9.

Basic mechanisms of calcific aortic valve disease.

Mathieu P, Boulanger MC.

Can J Cardiol. 2014 Sep;30(9):982-93. doi: 10.1016/j.cjca.2014.03.029. Review.

PMID:
25085215
10.

Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves.

Alexopoulos A, Bravou V, Peroukides S, Kaklamanis L, Varakis J, Alexopoulos D, Papadaki H.

Int J Cardiol. 2010 Mar 4;139(2):142-9. doi: 10.1016/j.ijcard.2008.10.014.

PMID:
19019468
11.

Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.

Kaden JJ, Dempfle CE, Grobholz R, Fischer CS, Vocke DC, Kiliç R, Sarikoç A, Piñol R, Hagl S, Lang S, Brueckmann M, Borggrefe M.

Cardiovasc Pathol. 2005 Mar-Apr;14(2):80-7.

PMID:
15780799
12.

New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review.

Perrotta I, Russo E, Camastra C, Filice G, Di Mizio G, Colosimo F, Ricci P, Tripepi S, Amorosi A, Triumbari F, Donato G.

Histopathology. 2011 Sep;59(3):504-13. doi: 10.1111/j.1365-2559.2011.03977.x. Review.

PMID:
22034890
13.

Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve.

Bouchareb R, Mahmut A, Nsaibia MJ, Boulanger MC, Dahou A, Lépine JL, Laflamme MH, Hadji F, Couture C, Trahan S, Pagé S, Bossé Y, Pibarot P, Scipione CA, Romagnuolo R, Koschinsky ML, Arsenault BJ, Marette A, Mathieu P.

Circulation. 2015 Aug 25;132(8):677-90. doi: 10.1161/CIRCULATIONAHA.115.016757.

14.

Insights into the use of biomarkers in calcific aortic valve disease.

Beckmann E, Grau JB, Sainger R, Poggio P, Ferrari G.

J Heart Valve Dis. 2010 Jul;19(4):441-52. Review.

15.

Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.

Pasipoularides A.

J Cardiovasc Transl Res. 2016 Apr;9(2):102-18. doi: 10.1007/s12265-016-9679-z. Review.

PMID:
26891845
16.

Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention.

Parolari A, Loardi C, Mussoni L, Cavallotti L, Camera M, Biglioli P, Tremoli E, Alamanni F.

Eur J Cardiothorac Surg. 2009 Mar;35(3):493-504. doi: 10.1016/j.ejcts.2008.11.033. Review.

PMID:
19162497
17.

Tumor necrosis factor-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway.

Yu Z, Seya K, Daitoku K, Motomura S, Fukuda I, Furukawa K.

J Pharmacol Exp Ther. 2011 Apr;337(1):16-23. doi: 10.1124/jpet.110.177915.

18.

Angiotensin receptor blockers are associated with reduced fibrosis and interleukin-6 expression in calcific aortic valve disease.

Côté N, Mahmut A, Fournier D, Boulanger MC, Couture C, Després JP, Trahan S, Bossé Y, Pagé S, Pibarot P, Mathieu P.

Pathobiology. 2014;81(1):15-24. doi: 10.1159/000350896.

PMID:
23969418
19.

Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.

Jung JJ, Razavian M, Challa AA, Nie L, Golestani R, Zhang J, Ye Y, Russell KS, Robinson SP, Heistad DD, Sadeghi MM.

J Nucl Med. 2015 Jun;56(6):933-8. doi: 10.2967/jnumed.114.152355.

20.

Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis.

Mohty D, Pibarot P, Després JP, Côté C, Arsenault B, Cartier A, Cosnay P, Couture C, Mathieu P.

Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):187-93.

Items per page

Supplemental Content

Support Center